Companies / TG Therapeutics Inc / Activity
Activity — TG Therapeutics Inc
122 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Victory Capital Management, Inc. 13F manager | Trim | Common stock | $-3.44M | -63K -42.36% | 85,297 0.06% of shares | low |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Trim | Common stock | $-3.66M | -110K -15.75% | 590,047 0.39% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | Add | Common stock | $4.12M | +274K +53.13% | 790,093 0.52% of shares | low |
| Q1 2024 as of | Barclays PLC 13F manager | Trim | Common stock | $-4.13M | -272K -63.46% | 156,380 0.10% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Add | Common stock | $4.37M | +80K +51.02% | 235,481 0.15% of shares | low |
| Q2 2026 as of | The PNC Financial Services Group, Inc. 13F manager | Add | Common stock | $4.39M | +80K +828.49% | 89,646 0.06% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common stock | $4.86M | +208K +149.08% | 347,057 0.23% of shares | low |
| Q1 2026 as of | Bridgewater Associates, LP 13F manager | Trim | Common stock | $-5.26M | -158K -33.72% | 311,415 0.20% of shares | medium |
| Q3 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-5.86M | -162K -26.16% | 458,225 0.30% of shares | medium |
| Q1 2026 as of | Principal Financial Group Inc 13F manager | Trim | Common stock | $-6.05M | -182K -21.50% | 665,526 0.43% of shares | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common stock | $6.69M | +224K +35.82% | 851,107 0.56% of shares | medium |
| Q1 2026 as of | AQR Capital Management, LLC 13F manager | Add | Common stock | $6.92M | +208K +153.07% | 344,189 0.22% of shares | medium |
| Q2 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-7.63M | -307K -38.86% | 483,082 0.32% of shares | medium |
| Q1 2026 as of | Clearbridge Investments, LLC 13F manager | Trim | Common stock | $-7.88M | -237K -6.88% | 3,210,930 2.10% of shares | medium |
| Q4 2025 as of | Norges Bank 13F manager | Exit | Common stock | $-8.61M | -218K -100.00% | 0 | medium |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Add | Common stock | $9.08M | +273K +39.99% | 957,026 0.63% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $11.07M | +202K +0.92% | 22,050,045 14.41% of shares | medium |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | Common stock | $11.32M | +341K | 340,900 0.22% of shares | medium |
| Q2 2025 as of | Barclays PLC 13F manager | Add | Common stock | $13.22M | +367K +145.18% | 620,546 0.41% of shares | medium |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $16.01M | +482K +45.44% | 1,542,312 1.01% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common stock | $-18.38M | -553K -81.86% | 122,587 0.08% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Trim | Common stock | $-38.10M | -694K -8.18% | 7,786,471 5.09% of shares | medium |